Science & Research
American Heart Association Launches Initiative to Accelerate Aortic Stenosis Diagnosis and Clinical Trial Access
The American Heart Association has launched a new initiative to improve early diagnosis of aortic stenosis and increase participation in clinical trials, potentially transforming care for this serious heart condition that often goes undiagnosed until advanced stages.
NanoViricides to Present Broad-Spectrum Antiviral Pipeline at Spartan Capital Investor Conference
NanoViricides will present its clinical-stage antiviral drug pipeline at the Spartan Capital Investor Conference, highlighting the potential significance of its platform technology for treating multiple viral diseases including RSV, COVID-19, influenza, and other respiratory infections.
Nvidia Introduces NVQLink System Connecting AI Chips to Quantum Computers
Nvidia's new NVQLink system bridges quantum computers with AI chips, potentially accelerating breakthroughs in medicine and materials science while positioning the company at the forefront of hybrid computing technology.
Cybin Chief Medical Officer to Present at Prestigious 2025 Milken Institute Health Summit
Cybin Inc.'s Chief Medical Officer will participate in the 2025 Milken Institute Future of Health Summit, highlighting the company's advanced clinical-stage mental health treatments and their potential to address significant unmet medical needs.
Quick Bystander CPR Within Five Minutes Nearly Doubles Pediatric Cardiac Arrest Survival
New research shows that initiating CPR within five minutes of a child's cardiac arrest can nearly double survival rates, highlighting the critical importance of immediate bystander intervention for pediatric emergencies.
Optimal Cardiovascular Health May Offset Dementia Risk in Type 2 Diabetes Patients
New research suggests that maintaining optimal cardiovascular health through the American Heart Association's Life's Essential 8 metrics can significantly reduce the risk of cognitive decline and dementia in people with Type 2 diabetes, even for those with high genetic risk.
Hidden Atrial Dysfunction Identified as Stroke Risk Factor in Heart Muscle Disease Patients
A new study reveals that people with transthyretin amyloid cardiomyopathy face significantly higher stroke risk when they have atrial electromechanical dysfunction, and researchers have developed a noninvasive assessment tool to identify those who might benefit from preventive treatments.
Long-Term Melatonin Use Linked to Increased Heart Failure Risk in Insomnia Patients, Study Finds
A preliminary study suggests adults with insomnia who used melatonin supplements for at least one year had significantly higher rates of heart failure diagnosis, hospitalization and death compared to non-users, raising important safety concerns about the widely available sleep aid.
Combining Healthy Lifestyle Habits with GLP-1 Medications Reduces Cardiovascular Risk in Type 2 Diabetes Patients
A study of over 63,000 veterans with Type 2 diabetes found that combining GLP-1 receptor agonist medications with at least six healthy lifestyle habits reduced cardiovascular event risk by 50% compared to standard care alone.
Combined Biomarker Analysis Reveals Triple Heart Attack Risk in High-Risk Individuals
A new study shows that analyzing three specific biomarkers together can identify individuals with nearly triple the risk of heart attack, potentially enabling earlier intervention and personalized prevention strategies.
Low-Dose Aspirin Shows Cardiovascular Benefits for High-Risk Type 2 Diabetes Patients
A preliminary study suggests adults with Type 2 diabetes and moderate-to-high cardiovascular risk who take low-dose aspirin experience significantly lower rates of heart attack, stroke, and death compared to non-users, though bleeding risks require careful consideration.
Nighttime Light Pollution Linked to Increased Heart Disease Risk Through Brain Stress Response
A new study reveals that exposure to artificial light at night increases heart disease risk by triggering stress-related brain activity and arterial inflammation, highlighting light pollution as a modifiable environmental health factor.
Foremost Clean Energy Reports Higher Uranium Grades at Saskatchewan Property
Foremost Clean Energy's final assay results from its Hatchet Lake Uranium Property confirm significantly higher uranium grades, potentially indicating proximity to a larger mineralizing system in the Athabasca Basin region.
Lifordi Immunotherapeutics Advances Glucocorticoid ADC LFD-200 into Phase 1 Rheumatoid Arthritis Trial Following Promising Nonclinical Data
Lifordi Immunotherapeutics has initiated Phase 1 clinical trials for LFD-200, a novel antibody-drug conjugate that delivers glucocorticoids directly to immune cells, potentially overcoming the systemic toxicity limitations that have restricted steroid use in autoimmune diseases for decades.
Oncotelic Therapeutics to Present Novel Breast Cancer Treatment Data at 2025 Symposium
Oncotelic Therapeutics will present clinical data for its investigational breast cancer treatment Sapu003 at the 2025 San Antonio Breast Cancer Symposium, potentially offering improved efficacy and reduced toxicity for patients with HR⁺/HER2⁻ metastatic breast cancer.
Oncotelic Therapeutics Featured in Editorial on Nanomedicine Advances in Oncology
Oncotelic Therapeutics' inclusion in a NetworkNewsWire editorial highlights how its Deciparticle platform represents significant progress in nanomedicine for improving cancer drug delivery and reducing toxicity.
AMD and IBM Partnership Advances Quantum Computing Error Correction Using Standard Chips
AMD shares surged nearly 8% after IBM announced that existing AMD processors can run critical quantum computing error correction algorithms, marking a significant advancement in making quantum technology more commercially viable.
Nanomedicine Breakthroughs Reshape Cancer Treatment Through Enhanced Drug Delivery
Advances in nanomedicine delivery systems are addressing critical limitations in cancer therapy by improving drug bioavailability and targeting while reducing toxicity, potentially transforming treatment standards across the oncology landscape.
NanoViricides Reports Promising Anti-Measles Results for Broad-Spectrum Antiviral Candidate NV-387
NanoViricides' experimental drug NV-387 demonstrates strong efficacy against Measles in preclinical studies, potentially addressing the critical gap in approved treatments for the resurgent viral disease.
GeoVax Vaccine Data Aligns With New IDSA Guidelines for Protecting Immunocompromised Patients
GeoVax's GEO-CM04S1 vaccine demonstrates robust T-cell responses and cross-variant durability in immunocompromised populations, addressing critical gaps identified in new IDSA guidelines that show current COVID-19 vaccines provide only moderate, short-lived protection for vulnerable patients.
Quantum Art Achieves Breakthrough in Quantum Circuit Efficiency Through NVIDIA Partnership
Quantum Art's collaboration with NVIDIA has resulted in 10X circuit depth compression and 30% error reduction, accelerating the path toward commercially viable quantum computing applications.
Viral Infections Significantly Increase Heart Attack and Stroke Risk, Study Finds
New research reveals that both acute infections like influenza and COVID-19 and chronic viral infections including HIV and hepatitis C substantially elevate cardiovascular disease risks, highlighting the importance of preventive measures including vaccination.
New Book Examines Lasting Impact of War of the Worlds Broadcast 87 Years Later
William Elliott Hazelgrove's new book 'Dead Air' explores how Orson Welles' 1938 radio drama created America's first viral media event, revealing important lessons about media influence and mass psychology that remain relevant today.
Medical Cannabis Access Linked to Reduced Opioid Use Among Cancer Surgery Patients
A new study reveals that states with medical cannabis dispensaries show decreased opioid prescriptions for cancer surgery patients but increased non-treatment hospital visits, highlighting the complex implications of cannabis policy on pain management and healthcare utilization.
Glioblastoma Remission Rates Remain Challenging Despite Treatment Advances
Only 25% of glioblastoma patients experience remission lasting at least two years, highlighting the urgent need for improved treatments for this aggressive brain cancer.
Oncotelic's Nanomedicine Platform Advances Cancer Treatment Through Enhanced Drug Delivery
Oncotelic Therapeutics' Deciparticle platform represents a significant advancement in nanomedicine that improves drug bioavailability and therapeutic effectiveness in oncology treatments.
Quantumzyme Showcases Sustainable Pharmaceutical Innovation at Global Enzyme Engineering Conference
Quantumzyme Corp.'s participation in the Enzyme Engineering XXVIII Conference highlights the company's advancements in eco-friendly pharmaceutical manufacturing through computational enzyme engineering.
New IDSA Guidelines Highlight Critical Need for Tailored COVID-19 Vaccines for Immunocompromised Population
GeoVax's GEO-CM04S1 vaccine addresses the significant protection gap for over 40 million immunocompromised Americans who experience limited effectiveness from current COVID-19 vaccines, as highlighted by new Infectious Diseases Society of America guidelines.
Circadian Rhythm Disruptions Linked to Increased Cardiometabolic Disease Risk, American Heart Association Warns
The American Heart Association's new scientific statement reveals that disruptions to the body's internal clock significantly increase risks for obesity, Type 2 diabetes, high blood pressure and cardiovascular disease, highlighting the importance of circadian alignment for preventive health strategies.
Dr. Hos Loftus Earns 2025 Castle Connolly Top Doctor Recognition for Integrated Neurology and Psychology Care
Dr. Hos Loftus has been recognized as a 2025 Castle Connolly Top Doctor for his innovative integrated approach to neurological and psychological care at Carolinas Institute for Neurology and Psychology, highlighting the growing importance of holistic treatment models in modern healthcare.